EGFR and breast carcinoma: Farghadani and Naidu [56], Mohammadian et al. [258], and Vinod et al. [259] found that the combination of curcumin and these chemotherapeutic agents downregulated HER2 and EGFR, which are often overexpressed in breast cancer, inhibited cell proliferation, and induced apoptosis.